JENNIFER MCBRYDE: Open Payments
NPI 1861597080 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 5 payments from 4 companies in 2025. Trend: 2023 $893 · 2024 $432 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $268 |
| ORPHALAN INC | 1 | $147 |
| Intercept Pharmaceuticals, Inc. | 1 | $120 |
| ABBVIE INC. | 1 | $98 |
Products named: CUVRIOR, Livdelzi, OCALIVA, MAVYRET.
Industry payments across TX — which companies pay providers there.
